These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 8370446)

  • 1. Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations.
    Seeger W; Grube C; Günther A; Schmidt R
    Eur Respir J; 1993 Jul; 6(7):971-7. PubMed ID: 8370446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteolytic cleavage of fibrinogen: amplification of its surfactant inhibitory capacity.
    Seeger W; Grube C; Günther A
    Am J Respir Cell Mol Biol; 1993 Sep; 9(3):239-47. PubMed ID: 8398160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface properties and sensitivity to protein-inhibition of a recombinant apoprotein C-based phospholipid mixture in vitro--comparison to natural surfactant.
    Seeger W; Thede C; Günther A; Grube C
    Biochim Biophys Acta; 1991 Jan; 1081(1):45-52. PubMed ID: 1991155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential sensitivity to fibrinogen inhibition of SP-C- vs. SP-B-based surfactants.
    Seeger W; Günther A; Thede C
    Am J Physiol; 1992 Mar; 262(3 Pt 1):L286-91. PubMed ID: 1550251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of hydrophobic apoproteins as constituents of clinical exogenous surfactants.
    Hall SB; Venkitaraman AR; Whitsett JA; Holm BA; Notter RH
    Am Rev Respir Dis; 1992 Jan; 145(1):24-30. PubMed ID: 1731593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance of different surfactant preparations to inactivation by meconium.
    Herting E; Rauprich P; Stichtenoth G; Walter G; Johansson J; Robertson B
    Pediatr Res; 2001 Jul; 50(1):44-9. PubMed ID: 11420417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity and inhibition resistance of a phospholipase-resistant synthetic surfactant in rat lungs.
    Wang Z; Chang Y; Schwan AL; Notter RH
    Am J Respir Cell Mol Biol; 2007 Oct; 37(4):387-94. PubMed ID: 17556674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biophysical models in investigations of exogenous surfactant activities on the surface tension and their theurapeutic effectiveness].
    Todorov R; Iordanova A; Georgiev GA; Petkova Kh; Stoimenova E; Georgieva R; Khristova E; Vasiliev Kh; Lalchev Z
    Akush Ginekol (Sofiia); 2007; 46 Suppl 1():29-36. PubMed ID: 18175392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of palmitic acid in pulmonary surfactant: enhancement of surface activity and prevention of inhibition by blood proteins.
    Cockshutt AM; Absolom DR; Possmayer F
    Biochim Biophys Acta; 1991 Sep; 1085(2):248-56. PubMed ID: 1892895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biophysical inhibition of synthetic vs. naturally-derived pulmonary surfactant preparations by polymeric nanoparticles.
    Beck-Broichsitter M; Ruppert C; Schmehl T; Günther A; Seeger W
    Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):474-81. PubMed ID: 24184425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of exogenous pulmonary surfactants on mortality rate in neonatal respiratory distress syndrome: A network meta-analysis of randomized controlled trials.
    Zhang L; Cao HY; Zhao S; Yuan LJ; Han D; Jiang H; Wu S; Wu HM
    Pulm Pharmacol Ther; 2015 Oct; 34():46-54. PubMed ID: 26296793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple mechanisms of lung surfactant inhibition.
    Holm BA; Wang Z; Notter RH
    Pediatr Res; 1999 Jul; 46(1):85-93. PubMed ID: 10400140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surfactant protein SP-B counteracts inhibition of pulmonary surfactant by serum proteins.
    Friedrich W; Schmalisch G; Stevens PA; Wauer RR
    Eur J Med Res; 2000 Jul; 5(7):277-82. PubMed ID: 10903187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of synthetic surfactants to albumin inhibition in preterm rabbits.
    Mbagwu N; Bruni R; Hernández-Juviel JM; Waring AJ; Walther FJ
    Mol Genet Metab; 1999 Jan; 66(1):40-8. PubMed ID: 9973546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biophysical inhibition of synthetic phospholipid-lung surfactant apoprotein admixtures by plasma proteins.
    Venkitaraman AR; Baatz JE; Whitsett JA; Hall SB; Notter RH
    Chem Phys Lipids; 1991; 57(1):49-57. PubMed ID: 2060063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Commercial versus native surfactants. Surface activity, molecular components, and the effect of calcium.
    Bernhard W; Mottaghian J; Gebert A; Rau GA; von Der HARDT H; Poets CF
    Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 1):1524-33. PubMed ID: 11029372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung surfactant phospholipids associate with polymerizing fibrin: loss of surface activity.
    Seeger W; Elssner A; Günther A; Krämer HJ; Kalinowski HO
    Am J Respir Cell Mol Biol; 1993 Aug; 9(2):213-20. PubMed ID: 8338688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Content of dipalmitoyl phosphatidylcholine in lung surfactant: ramifications for surface activity.
    Holm BA; Wang Z; Egan EA; Notter RH
    Pediatr Res; 1996 May; 39(5):805-11. PubMed ID: 8726232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised clinical trial of two treatment regimens of natural surfactant preparations in neonatal respiratory distress syndrome.
    Speer CP; Gefeller O; Groneck P; Laufkötter E; Roll C; Hanssler L; Harms K; Herting E; Boenisch H; Windeler J
    Arch Dis Child Fetal Neonatal Ed; 1995 Jan; 72(1):F8-13. PubMed ID: 7743295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral cell wall lipids of Mycobacterium tuberculosis are inhibitory to surfactant function.
    Wang Z; Schwab U; Rhoades E; Chess PR; Russell DG; Notter RH
    Tuberculosis (Edinb); 2008 May; 88(3):178-86. PubMed ID: 18155644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.